NNE’s latest article appearing on Pharmaceutical Online focuses on regulatory opinion around aseptic production technology, including VHP sterilization. Regulatory authorities are increasing the pressure to remove human intervention from biopharma aseptic filling, resulting in fully automated systems.
Vanrx Pharmasystems’ Microcell Vial filler was among 16 innovation award winners hosted by industry magazine, The Medicine Maker. Of the 16 winners, one will be chosen as the most groundbreaking technology. Vote here for the Microcell Vial Filler!
On November 6, 2018, Dr. Nitin Rathore, Director of Process Development at Amgen, presented 'Implementation of Next-Generation Technologies in Biomanufacturing' at the American Association of Pharmaceutical Scientists (AAPS) Pharma 360 conference in Washington, D.C.
The transition from blanket therapeutic approaches to customized treatments for a single patient is referred to as precision medicine. This article discusses two scientific tools and how they influence the future of precision medicine: Next-generation sequencing (NGS) and CRISPR-Cas9.
On November 6 at AAPS, Markus Stübchen, Roche’s Global Technical Lead for Large Molecule Drug Product & Clean Utilities, delivered the presentation Novel Approaches for Robotics Use in Sterile Manufacturing. The presentation described how Roche / Genentech will use Vanrx's SA25 as part of a "network" strategy.
Deloitte has named Vanrx Pharmasystems as the fastest growing technology company in Canada on its 2018 Technology Fast 50 list. The Fast 50 program celebrates innovation in the form of rapid revenue growth. Vanrx’s revenue growth percentage was 19,342%, placing it first on the overall list.